Robert Busch

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 206 citations · Full text

Molecular Pharmacology, Hypertension, Resistant Hypertension +9

Differential DNA methylation marks and gene comethylation of COPD in African-Americans with COPD exacerbations

Robert Busch, Weiliang Qiu, Jessica Lasky‐Su et al. · Respiratory Research · 2016 · 71 citations · Full text

Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency

Ganesh Raghu, Marya Ghazipura, Thomas R. Fleming et al. · American Journal of Respiratory and Critical Care Medicine · 2024 · 65 citations · Full text

Diagnosis of acute myocardial infarction in the emergency room

John M. Eisenberg, Leonard N. Horowitz, Robert Busch et al. · Journal of Community Health · 1979 · 60 citations

Cardiovascular Disease, Coronary Unit, Myocardial Infarction +8

Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival

Gabriela Oprea‐Ilies, Erhard Haus, L Sackett-Lundeen et al. · Breast Cancer Research and Treatment · 2012 · 46 citations · Full text